Literature DB >> 1417119

Ankylosing spondylitis and monoclonal gammopathies.

G Renier1, J C Renier, M Gardembas-Pain, A Chevailler, M Boasson, D Hurez.   

Abstract

From 1960 to 1990, 557 patients with ankylosing spondylitis (428 men, 129 women) were diagnosed and indexed in the department of rheumatology. Monoclonal gammopathies were found in seven (five men, two women) patients (1.3%). With one exception, ankylosing spondylitis preceded monoclonal gammopathies by many years. The distribution of the isotypes of the mIg found in these seven patients was striking when compared either with previous reports of an association between ankylosing spondylitis and monoclonal gammopathies or with local data on the epidemiology of monoclonal gammopathies: five patients with IgG, four of them of the lambda (lambda) type, and two IgM, both of the kappa (kappa) type were found; no patients with mIgA were recorded. Two patients were HLA-B27 positive and had slight and transient monoclonal gammopathies, whereas three subjects were HLA-B27 negative and had important spikes, corresponding in two subjects to malignant diseases. This observation raises the question of whether the coexistence of HLA-B27 and ankylosing spondylitis might provide a protective action. Epidemiological studies are required to clarify such points.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417119      PMCID: PMC1004801          DOI: 10.1136/ard.51.8.951

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Clinical features and course of ankylosing spondylitis; as seen in a follow-up of 222 hospital referred cases.

Authors:  M WILKINSON; E G BYWATERS
Journal:  Ann Rheum Dis       Date:  1958-06       Impact factor: 19.103

Review 2.  Clinical and radiographic features of ankylosing spondylitis.

Authors:  S M van der Linden
Journal:  Curr Opin Rheumatol       Date:  1990-08       Impact factor: 5.006

Review 3.  Amyloidosis in the rheumatic diseases.

Authors:  V Dhillon; P Woo; D Isenberg
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

4.  [Erythrocyte sedimentation rate and serum immunoglobulins in rheumatic pelvispondylitis].

Authors:  M Dougados; Y Gaudouen; M Blan; P Boumier; D Raichvarg; B Amor
Journal:  Rev Rhum Mal Osteoartic       Date:  1987-03

5.  [The "paraproteins" of types Ig G and Ig A in subjects without Kahler's disease].

Authors:  F Danon; J P Clauvel; M Seligmann
Journal:  Rev Fr Etud Clin Biol       Date:  1967 Aug-Sep

6.  Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital.

Authors:  V Malacrida; D De Francesco; G Banfi; F A Porta; P G Riches
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

7.  HLA antigens and monoclonal gammapathy.

Authors:  J P Saleün; P Youinou; P Le Goff; G Le Menn; J F Morin
Journal:  Tissue Antigens       Date:  1979-03

8.  Significance of 801 monoclonal proteins detected during 7 years of screening in a district general hospital.

Authors:  L Smith; R A Adams; C Burston
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

9.  Serum IgG, IgM, and IgA levels in ankylosing spondylitis.

Authors:  E M Veys; M van Leare
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

10.  [Immunologic aspects of ankylosing spondylarthritis].

Authors:  P Saliou; A Thabaut; J L Durosoir; S Pattin; P Doury
Journal:  Rev Rhum Mal Osteoartic       Date:  1982-01
View more
  5 in total

1.  Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma.

Authors:  Normann Steiner; Georg Göbel; Daniela Michaeler; Anna-Luise Platz; Wolfgang Prokop; Anna Maria Wolf; Dominik Wolf; Christina Duftner; Eberhard Gunsilius
Journal:  Blood Adv       Date:  2021-03-23

2.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

3.  Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients.

Authors:  John P Bida; Robert A Kyle; Terry M Therneau; L Joseph Melton; Matthew F Plevak; Dirk R Larson; Angela Dispenzieri; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

4.  Oligo-secretory myeloma in a patient with ankylosing spondylitis.

Authors:  Eva Perez-Pampin; Joaquin Campos; Jorge Blanco; Manuel Perez-Encinas; Antonio Mera
Journal:  Rheumatol Int       Date:  2009-07-07       Impact factor: 2.631

5.  Widespread scleredema accompanied with a monoclonal gammopathy in a patient with advanced ankylosing spondylitis.

Authors:  Hyun Kyu Chang; You Chan Kim; Bum Sun Kwon
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.